Bellerophon Therapeutics Reveals Top-Line PRESERVATION I Findings on Bioabsorbable Cardiac Matrix
Clinical stage biotherapeutics company Bellerophon Therapeutics, Inc. has just revealed the top-line results of its PRESERVATION I clinical study forĀ Bioabsorbable Cardiac Matrix (BCM), an experimental, implantable medical device currently being ... Read more